The rain-making, 2X exit founder

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Andrea Wagner, CEO at PharmaPhixx. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Andrea, covering: Building a 'not very pretty' business, to an eventual exit after 10 years The reluctant founding of Berkshire Sterile Manufacturing (Now Sharp)...making new mistakes on her encore journey of growth and a second exit Why company leaders should think of decision-making like trees Pro business development tips from a seasoned entrepreneur with growth hard-wired into her Her views on the current market and what opportunities lie ahead for the brave Dr. Andrea N. Wagner is a serial entrepreneur renowned for co-founding and advancing two contract sterile manufacturing companies, with her latest venture acquired by Sharp Services in October 2023. She passionately advocates for women in business, serving on the board of Women Entrepreneurs Grow Global (WEGG), co-founding Herizon Funding to support women-owned businesses, and contributing as an advisory board member at the Boston Museum of Science. As CEO of PharmaPhixx and founder of the sweater brand LuxLined in 2024, Andrea continues to diversify her business interests. Additionally, she established the Andrea Wagner Scholarship Fund to support young women pursuing STEM degrees. Currently, she is writing a book, focusing on empowering women in STEM to ascend to leadership roles. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating! Molecule to Market is also sponsored by Bora Pharma (boracdmo.com) and Charles River (www.criver.com), and supported by ramarketing.